Nyumbani › Multiple Sclerosis › Florida › Naples
Majaribio ya kliniki ya Multiple Sclerosis katika Naples, FL
Masomo 4 ya Multiple Sclerosis yanatafuta washiriki katika vituo vya Naples na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
InaajiriHatua 2
- Aqualane Clinical Research, Naples
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
InaajiriUtafiti wa uchunguzi
- TG Therapeutics Investigational Trial Site, Naples
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
InaajiriHatua 3
- Aqualane Clinical Research- Site Number : 8400026, Naples
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
InaajiriHatua 3
- Aqualane Clinical Research, Naples
Majaribio ya Multiple Sclerosis katika miji mingine
- New York City, NYUtafiti 17
- Chicago, ILUtafiti 15
- Boston, MAUtafiti 14
- Washington, DCUtafiti 13
- Cleveland, OHUtafiti 9
- St. Louis, MOUtafiti 8
- Birmingham, ALUtafiti 8
- Kansas City, KSUtafiti 8
- San Francisco, CAUtafiti 8
- Columbus, OHUtafiti 7
- Aurora, COUtafiti 7
- Baltimore, MDUtafiti 7
Masomo mengine katika Naples
- Ugonjwa wa AlzheimerUtafiti 7
- Magonjwa ya Mapafu ya InterstitialUtafiti 5
- Kitisho cha Huzuni KikubwaUtafiti 4
- Magonjwa ya Moyo na Mishipa ya DamuUtafiti 4
- UnenepuUtafiti 4
- Uzito Kupita KiasiUtafiti 4
- Shinikizo la Juu la MapafuUtafiti 3
- Fibrillation ya AtriumUtafiti 3
- Kushindwa kwa MoyoUtafiti 3
- Stenosis ya Valvu ya AortaUtafiti 3
- Ugonjwa wa ParkinsonUtafiti 3
- Magonjwa ya NevaUtafiti 3
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.